Clinical-stage biotech developing nasal sprays for protection against respiratory infections.
Founders
Koenraad Wiedhaup(Netherlands · ♂)— A Dutch life scientist and former McKinsey life-sciences partner, he co-founded Leyden Labs in 2020 to develop intranasal antibody medicines for pandemic preparedness, serving as CEO.
Jaap Goudsmit(Netherlands · ♂)— A virologist and Crucell co-founder, he brought deep vaccine science to co-found Leyden Labs and tackle respiratory viruses at the mucosal level.
Ronald Brus(Netherlands · ♂)— A serial biotech entrepreneur and former Crucell CEO who reunited with his Crucell colleagues to co-found Leyden Labs for pandemic-ready intranasal medicines.
Dinko Valerio(Netherlands · ♂)— A founder of vaccine pioneer Crucell, he joined the Crucell veteran team to co-found Leyden Labs and pursue broad-spectrum antiviral protection.
Team & hubs
In the network
Shares the most investors with (number = shared investors):